Mucormycosis, also known as black fungus, is a rare but potentially life-threatening fungal infection caused by molds belonging to the order Mucorales. While these molds are commonly found in the environment, mucormycosis typically affects individuals with weakened immune systems, such as those with uncontrolled diabetes, cancer, or immunocompromising conditions. The infection usually begins in the sinuses or lungs after inhaling fungal spores, but it can rapidly spread to other organs, including the brain, eyes, and skin, leading to severe complications and mortality if left untreated. Symptoms of mucormycosis vary depending on the site of infection but may include fever, headache, facial pain, nasal congestion, and black discoloration or necrosis of the affected tissue. Early diagnosis and prompt initiation of antifungal therapy are crucial for improving outcomes in patients with mucormycosis, highlighting the importance of heightened awareness and vigilance among healthcare professionals, especially in high-risk populations.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain